WHO Warns of Shortage of Obesity Treatment Drugs

The World Health Organization has issued a warning over a global shortage of medicines used to treat obesity, saying fewer than 10 percent of affected people can access them.

Limited Access to Obesity Medicines

WHO says more than one billion people worldwide are living with obesity.
However, only a small fraction can afford medicines that help manage the condition.

These drugs include popular treatments such as Wegovy, which have shown strong results in weight reduction.

Despite growing demand, access remains highly limited.

Obesity Rates Expected to Rise by 2030

According to WHO estimates, the number of people living with obesity could exceed two billion by 2030 if no urgent action is taken.

Health experts warn that obesity increases the risk of diabetes, heart disease, and other chronic illnesses.

As a result, pressure on health systems continues to grow.

High Costs and Supply Constraints

WHO identified several barriers limiting access to obesity treatment drugs.

These include high prices, limited production, and challenges in distributing the medicines to markets.

The organization noted that current supply levels remain far below global demand.

Therefore, millions of patients are unable to receive proper treatment.

WHO Urges Governments to Act

WHO has encouraged governments to purchase and distribute obesity medicines to people in need.

The agency stressed that public health systems must play a stronger role in improving access.

Such efforts could help slow the rapid rise in obesity rates.

Obesity Is a Treatable Chronic Disease

WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized that obesity is a long-term condition.

He said it can be treated successfully with sustained medical care.

“While medicines alone are not enough to solve the global obesity crisis, GLP-1 drugs can help many people manage this condition,” he said.

Changing Perceptions About Obesity

WHO noted that the introduction of obesity medicines has changed how people view the condition.

Many now recognize obesity as a serious medical disease rather than a lifestyle choice.

This shift has helped reduce stigma and encouraged people to seek treatment.

Long-Term Treatment Still Required

WHO advises that patients may need to use obesity medicines for six months or longer.

Patients must also follow medical advice, including healthy eating and regular physical activity.

Experts stress that medication works best when combined with lifestyle changes.